Nasdaq
Managers’ transactions
12-11-2018
BioPorto A/S
Managers' Transactions
November 12, 2018
Company announcement no. 21
Managers’ transactions
BioPorto A/S has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below transactions related to shares in BioPorto A/S made by persons discharging managerial responsibilities in BioPorto A/S and/or persons closely related with them.
| 1. Details of the person discharging managerial responsibilities/person closely associated | |
| a) Name | Therazone ApS |
| 2 Reason for the notification | |
| a) Position/status | Closely associated person to Thomas Magnussen, Chairman of the Board of Directors |
| b) Initial notification/Amendment | Initial notification |
| 3 Details of the issuer | |
| a) Name | BioPorto A/S |
| b) LEI | 5299004SWFL5JAN4W830 |
| 4 Details of the transaction(s) | |
| a) Description of the financial instrument, type of instrument Identification code |
Shares ISIN: DK0011048619 |
| b) Nature of the transaction | Subscription in connection with a private placement |
| c) Price(s) and volume(s) | Price: DKK 3.93, Volume: 254,453 |
| d) Aggregated information | n/a |
| e) Date of the transaction | 2018-11-12 |
| f) Place of the transaction | Outside a trading venue |
| 1. Details of the person discharging managerial responsibilities/person closely associated | |
| a) Name | Torben Arnth Nielsen |
| 2 Reason for the notification | |
| a) Position/status | Deputy Chairman of the Board of Directors |
| b) Initial notification/Amendment | Initial notification |
| 3 Details of the issuer | |
| a) Name | BioPorto A/S |
| b) LEI | 5299004SWFL5JAN4W830 |
| 4 Details of the transaction(s) | |
| a) Description of the financial instrument, type of instrument Identification code |
Shares ISIN: DK0011048619 |
| b) Nature of the transaction | Subscription in connection with a private placement |
| c) Price(s) and volume(s) | Price: DKK 3.93, Volume: 38,168 |
| d) Aggregated information | n/a |
| e) Date of the transaction | 2018-11-12 |
| f) Place of the transaction | Outside a trading venue |
| 1. Details of the person discharging managerial responsibilities/person closely associated | |
| a) Name | Ole Larsen |
| 2 Reason for the notification | |
| a) Position/status | Chief Financial Officer |
| b) Initial notification/Amendment | Initial notification |
| 3 Details of the issuer | |
| a) Name | BioPorto A/S |
| b) LEI | 5299004SWFL5JAN4W830 |
| 4 Details of the transaction(s) | |
| a) Description of the financial instrument, type of instrument Identification code |
Shares ISIN: DK0011048619 |
| b) Nature of the transaction | Subscription in connection with a private placement |
| c) Price(s) and volume(s) | Price: DKK 3.93, Volume: 127,228 |
| d) Aggregated information | n/a |
| e) Date of the transaction | 2018-11-12 |
| f) Place of the transaction | Outside a trading venue |
For further information please contact:
Peter Mørch Eriksen, CEO
Gry Husby Larsen, Investor relations
Tel.: 45 29 00 00, e-mail investor@bioporto.com
Attachment